CompaniesByCap
TOVX
Theriva Biologics, Inc. (TOVX)
NYSE · Healthcare

Theriva Biologics, Inc. Cash Flow 2010–2011

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010
Operating Activities
Operating Cash Flow-16.7M-16.9M-19.0M-19.1M-12.9M-12.2M-13.9M-17.3M-20.2M-27.9M-38.9M-16.1M-7.7M-8.9M-2.9M-1.1M
Depreciation & Amort.108,000137,000135,00085,00087,000201,000240,000272,000245,000157,00072,00020,00043,000
Investing Activities
Capital Expenditure35,0001,000202,000116,00014,0009,00007,000212,000569,000501,00048,00036,00010,000012,000
Free Cash Flow-16.7M-16.9M-19.2M-19.2M-12.9M-12.2M-13.9M-17.3M-20.4M-28.5M-39.4M-16.1M-7.8M-8.9M-2.9M-1.2M
Financing Activities
Dividends Paid
Stock Buybacks

Theriva Biologics, Inc. Cash Flow — FAQ

Theriva Biologics, Inc. (TOVX) cash flow over the last 2 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TOVX's cash flow history?

The chart and table above show Theriva Biologics, Inc.'s cash flow by year and by quarter, including the growth rate.